36, 59-65 (1984)
Aoki, K., Kajiwara, M. and Oka, T.: The in
activation of [Met5]-enkephalin by bestatin
sensitive aminopeptidase, captopril-sensitive 10
peptidyl dipeptidase A and thiorphan-sensitive
endopeptidase-24.11 in mouse vas deferens.
Japan. J. Pharmacol. 40, 297-302 (1986)
3 Cue!lo, A.C.: Central distribution of opioid
peptides. Br. Med. Bull. 39, 11-16 (1983) 11
4 Oka, T., Negishi, K., Suda, M., Sawa, A., Fujino,
M. and Wakimasu, M.: Evidence that dynorphin
(1-1 3) acts as an agonist on opioid K-receptors.
Eur. J. Pharmacol. 77, 137-141 (1982) 12
5 Glowinski, J. and Iversen, L.L.: Regional studies
of catecholamines in the rat brain-I: the dis
position of [3H]norepinephrine, [3H]dopamine
and [3H]dopa in various regions of the brain. J. 13
Neurochem. 13, 655-669 (1966)
6 Lowry, O.H., Rosebrough, N.J., Farr, A.L. and
Randall, R.J.: Protein measurement with the
Folin phenol reagent. J. Biol. Chem. 193, 265
275 (1951) 14
7 Cohen, M.L., Geary, L.E. and Wiley, K.S.:
Enkephalin degradation in the guinea-pig ileum:
Effect of aminopeptidase inhibitors, puromycin
and bestatin. J. Pharmacol. Exp. Ther. 224,
379-385 (1983)
8 Barclay, R.K. and Phillipps, M.A.: Inhibition of 15
the enzymatic degradation of leu-enkephalin by
puromycin. Biochem. Biophys. Res. Commun.
81, 1119-1123 (1978)
Fulcher, I.S., Chaplin, M.F. and Kenny, A.J.:
